KATHERINE ROARTY: Open Payments
NPI 1407177496 · DERBY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 20 payments from 3 companies in 2025. Trend: 2023 $455 · 2024 $460 · 2025 $271
Food & beverage: $191Education: $80
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $174 |
| Regeneron Healthcare Solutions, Inc. | 1 | $80 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: NUCALA, DUPIXENT, TRELEGY ELLIPTA, BREZTRI.
Industry payments across CT — which companies pay providers there.
